Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schuler

Showing results (11-20 of 296) with videos related to

Pageof 30
Sort By:
Trends in Genetics : TIG|March 1, 2005
Transcription, apoptosis and p53: catch-22Martin Schuler, Douglas R Green
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Crizotinib in <i>ROS1</i> and <i>MET</i> Deregulated NSCLC-LetterMarcel Wiesweg, Martin Schuler, Hans-Ulrich Schildhaus
Deutsches Arzteblatt International|March 29, 2018
CUP Syndrome-Metastatic Malignancy with Unknown Primary TumorGregor Zaun, Martin Schuler, Ken Herrmann, et al.
Oncogene|October 10, 2003
The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspasesJavorina Milosevic, Sandra Hoffarth, Claudia Huber, et al.
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Treatment of early and locally advanced stages of non-small cell lung cancer]Marcel Wiesweg, Wilfried E Eberhardt, Martin Schuler, et al.
Cancer Cell|December 12, 2003
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcriptionJerry E Chipuk, Ulrich Maurer, Douglas R Green, et al.
Nanomedicine (London, England)|August 25, 2007
Biomedical interfaces: titanium surface technology for implants and cell carriersMartin Schuler, Diana Trentin, Marcus Textor, et al.
The Journal of Biological Chemistry|January 1, 2014
A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancerGesine Hoffmann, Frank Breitenbücher, Martin Schuler, et al.
Biomaterials|February 6, 2007
Systematic study of osteoblast and fibroblast response to roughness by means of surface-morphology gradientsTobias P Kunzler, Tanja Drobek, Martin Schuler, et al.
International Journal of Cardiology|January 22, 2019
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular diseaseMatthias Totzeck, Martin Schuler, Martin Stuschke, et al.
Pageof 30

Showing results (11-20 of 296) with videos related to

Sort By:
Pageof 30
Trends in Genetics : TIG|March 1, 2005
Transcription, apoptosis and p53: catch-22Martin Schuler, Douglas R Green
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Crizotinib in <i>ROS1</i> and <i>MET</i> Deregulated NSCLC-LetterMarcel Wiesweg, Martin Schuler, Hans-Ulrich Schildhaus
Deutsches Arzteblatt International|March 29, 2018
CUP Syndrome-Metastatic Malignancy with Unknown Primary TumorGregor Zaun, Martin Schuler, Ken Herrmann, et al.
Oncogene|October 10, 2003
The DNA damage-induced decrease of Bcl-2 is secondary to the activation of apoptotic effector caspasesJavorina Milosevic, Sandra Hoffarth, Claudia Huber, et al.
Innere Medizin (Heidelberg, Germany)|August 4, 2022
[Treatment of early and locally advanced stages of non-small cell lung cancer]Marcel Wiesweg, Wilfried E Eberhardt, Martin Schuler, et al.
Cancer Cell|December 12, 2003
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcriptionJerry E Chipuk, Ulrich Maurer, Douglas R Green, et al.
Nanomedicine (London, England)|August 25, 2007
Biomedical interfaces: titanium surface technology for implants and cell carriersMartin Schuler, Diana Trentin, Marcus Textor, et al.
The Journal of Biological Chemistry|January 1, 2014
A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancerGesine Hoffmann, Frank Breitenbücher, Martin Schuler, et al.
Biomaterials|February 6, 2007
Systematic study of osteoblast and fibroblast response to roughness by means of surface-morphology gradientsTobias P Kunzler, Tanja Drobek, Martin Schuler, et al.
International Journal of Cardiology|January 22, 2019
Cardio-oncology - strategies for management of cancer-therapy related cardiovascular diseaseMatthias Totzeck, Martin Schuler, Martin Stuschke, et al.
Pageof 30